ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

SEER Seer Inc

1,995
-0,065 (-3,16%)
11 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Seer Inc SEER NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,065 -3,16% 1,995 06:00:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,05 1,98 2,08 1,995 2,06
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:15EDGAR2Form 8-K - Current report
08.5.202422:05GLOBESeer Reports First Quarter 2024 Financial Results
08.5.202422:03GLOBESeer Launches New Technology Access Center in Europe to..
23.4.202422:05GLOBESeer to Report First Quarter 2024 Financial Results on May..
06.3.202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.2.202422:15EDGAR2Form 8-K - Current report
29.2.202422:05GLOBESeer Reports Fourth Quarter and Full Year 2023 Financial..
23.2.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:05GLOBESeer to Participate in the TD Cowen 44th Annual Health Care..
08.2.202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202414:00GLOBESeer Proteograph™ Enables Unprecedented Genetic Marker..
01.2.202422:05GLOBESeer to Report Fourth Quarter and Full Year 2023 Financial..
03.1.202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22.12.202322:10EDGAR2Form 8-K - Current report
21.12.202322:05GLOBESeer to Present at the J.P. Morgan 42nd Annual Health Care..
17.11.202322:58EDGAR2Form 8-K - Current report
10.11.202315:00GLOBESeer to Present at the Canaccord MedTech, Diagnostics and..
08.11.202315:00GLOBESeer Wins Proteomics Solution of the Year by BioTech..
07.11.202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:18EDGAR2Form 8-K - Current report
07.11.202322:05GLOBESeer Reports Third Quarter 2023 Financial Results
01.11.202314:00GLOBESeer Announces Addition of Panome Bio to Centers of..
19.10.202322:05GLOBESeer to Report Third Quarter 2023 Financial Results on..
08.9.202322:05GLOBESeer to Participate in Upcoming September Investor..
08.8.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:15EDGAR2Form 8-K - Current report
08.8.202322:05GLOBESeer Reports Second Quarter 2023 Financial Results
27.7.202322:05GLOBESeer to Present at the Canaccord Genuity 43rd Annual Growth..
21.7.202322:29EDGAR2Form 8-K - Current report
13.7.202322:05GLOBESeer to Report Second Quarter 2023 Financial Results on..
07.6.202315:00GLOBESeer Collaborates to Make Scalable, Unbiased Proteomics..
01.6.202315:00GLOBESeer Launches the Proteograph XT Assay Kit: Allowing Labs to..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock